Clinical Trial Update: New Biomarker for Alzheimer's Disease Diagnostic [NA]

View source ↗

Summary

A completed clinical trial reports a new biomarker for diagnosing Alzheimer's disease and mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | NA | Status: COMPLETED